LEMZOPARLIMAB
UNII 0H2XLR2IKW

Substance Identification & Data

This profile provides standardized clinical and technical data for Lemzoparlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0H2XLR2IKW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2377483-71-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0H2XLR2IKW

CAS Registry Number

2377483-71-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEMZOPARLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C163977

National Cancer Institute reference terminology for clinical and research data.

INN ID

11596

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-68

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lemzoparlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LEMZOPARLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4(228-PROLINE), ANTI-(HUMAN CD47 ANTIGEN) (HUMAN MONOCLONAL TJ011133 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TJ011133 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CD47 (INTEGRIN ASSOCIATED PROTEIN, IAP, MER6, OA3)), MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN (1-445) (VH (HOMO SAPIENS IGHV3-15*07 (93.9%) -(IGHD) -IGHJ3*02 (100%)) CDR-IMGT (8.10.9) (26-33.51-60.99-107) (1-118) -HOMO SAPIENS IGHG4*01 (100%), G4V5 H P10 (CH1 (119-216), HINGE 1-12 S10>P (226) (217-228), CH2 (229-338), CH3 (339-443), CHS (444-445)) (119-445)), (132-220')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-220') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (89.1%) -IGKJ2*01 (90%) Q120>G (106)) CDR-IMGT (12.3.9) (27-38.56-58.95-103) (1'-113') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (159), V101 (197) (114'-220')); DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, GLYCOFORM ALFA

LEMZOPARLIMAB [INN]

LEMZOPARLIMAB [USAN]

LEMZOPARLIMAB [WHO-DD]